Three doses of Pfizer and BioNTech’s COVID-19 vaccine may protect against the new omicron variant similarly well as two doses did against the original coronavirus …
The results disclosed by Pfizer and BioNTech on Monday could support full approvals in the U.S. and elsewhere, which in turn could help bolster vaccination …
